Administration of cyclophosphamide at different stages of follicular maturation in mice: effects on reproductive performance and fetal malformations.
about
Xenobiotic effects on ovarian preantral folliclesFertility preservation during cancer treatment: clinical guidelinesTRAIP is involved in chromosome alignment and SAC regulation in mouse oocyte meiosisPrevention of chemotherapy-induced ovarian damage: possible roles for hormonal and non-hormonal attenuating agentsLead level in seminal plasma may affect semen quality for men without occupational exposure to leadDoxorubicin-induced ovarian toxicity.Effect of Imatinib Coadministration on in Vitro Oocyte Acquisition and Subsequent Embryo Development in Cyclophosphamide-Treated MiceFertility preservation in patients with haematological disorders: a retrospective cohort study.Ovarian tissue cryopreservation followed by controlled ovarian stimulation and pick-up of mature oocytes does not impair the number or quality of retrieved oocytesCyclophosphamide in multiple sclerosis: scientific rationale, history and novel treatment paradigms.Prenatal exposure to urban air nanoparticles in mice causes altered neuronal differentiation and depression-like responses.Robo1/2 regulate follicle atresia through manipulating granulosa cell apoptosis in mice.Fertility preservation in female cancer patients.Fertility preservation in reproductive-age women facing gonadotoxic treatments.DNA damage induces a meiotic arrest in mouse oocytes mediated by the spindle assembly checkpoint.Oncofertility: combination of ovarian stimulation with subsequent ovarian tissue extraction on the day of oocyte retrieval.Human oocyte and ovarian tissue cryopreservation and its application.Failure of ovarian ablation with goserelin in a pre-menopausal breast cancer patient resulting in pregnancy: a case report and review of the literature.Prevention of ovarian damage and infertility in young female cancer patients awaiting chemotherapy--clinical approach and unsolved issues.Fertility, pregnancy and childbirth in patients with multiple sclerosis: impact of disease-modifying drugs.Optimizing outcomes from ovarian tissue cryopreservation and transplantation; activation versus preservation.Chemotherapy-induced damage to ovary: mechanisms and clinical impact.History of ABVD alters the number of oocytes vitrified after in vitro maturation in fertility preservation candidates.Patient perceptions of reproductive health counseling at the time of cancer diagnosis: a qualitative study of female California cancer survivors.Cryopreservation of in vitro matured oocytes in addition to ovarian tissue freezing for fertility preservation in paediatric female cancer patients before and after cancer therapy.Fertility preservation in breast cancer patients: IVF and embryo cryopreservation after ovarian stimulation with tamoxifen.Pregnancy outcomes in multiple sclerosis patients previously treated with cyclophosphamide.Somatic and reproductive development in pre-pubertal mice treated with cyclophosphamide and subsequent estrogen replacement.The Natural Carotenoid Crocetin and the Synthetic Tellurium Compound AS101 Protect the Ovary against Cyclophosphamide by Modulating SIRT1 and Mitochondrial Markers.Obesity alters phosphoramide mustard-induced ovarian DNA repair in mice.Low-dose metronomic delivery of cyclophosphamide is less detrimental to granulosa cell viability, ovarian function, and fertility than maximum tolerated dose delivery in the mouse.Doxorubicin-induced female reproductive toxicity: an assessment of ovarian follicular apoptosis, cyclicity and reproductive tissue histology in Wistar rats.Ovarian reserve and response to IVF and in vitro maturation treatment following chemotherapy.Effects of GnRHa on early embryonic development in mice receiving cyclophosphamide.Ovulated oocytes in adult mice derive from non-circulating germ cells.Early embryonic sensitivity to cyclophosphamide in cardiac differentiation from human embryonic stem cells.Licorice extract increases cyclophosphamide teratogenicity by upregulating the expression of cytochrome P-450 2B mRNA.
P2860
Q24634884-5FC03A8E-EDFD-44D6-9D37-3AEEB6C21BDDQ26823947-E54ACC4C-AC11-4D38-9674-51CB31F6E22CQ27329431-3F11BDFB-4B99-4249-8DE7-F32FBA3CBAD1Q28240178-03E346EE-8075-4E55-939D-0328B2C01533Q28391966-4305C14A-AEA6-4DE0-AAF5-1855DFDD7F46Q33729075-081807C3-0872-4CA1-ABBB-60EC60620200Q33936667-35935592-7162-4CBE-8B71-FAEF65205FB8Q34120772-8E9473AC-75E9-44F8-9105-B2A71E6D4B42Q34157016-5EB5834C-2702-4D88-B2DE-4FC0AB575D69Q34409273-A445A23F-658B-45E9-BAB0-17D6062AC98DQ34755370-9E1A69A8-31FF-4329-9AA3-827AC3AD4B4AQ35622578-C1CC9C53-F921-40F8-8C85-EF6C7E63E3D4Q35825586-860EB120-F6E9-4826-A11D-BC3D4EFA0657Q35934317-66CC759F-00A7-421A-B715-7E17378AC02AQ36319891-49193839-8022-4AF5-A5E0-37648A0D93C9Q36689214-394FB80B-6157-4106-BE72-E5E9C9931CF8Q37000756-D73849C3-991C-450A-BF08-4BD2EAF7BA32Q37871906-57B54081-3FCC-49C6-8648-D99363410A68Q37938748-5DF82F6A-FD15-455F-9EDC-A20264C5F20EQ38379249-AFE56D41-9EF2-4978-9B85-671504747CD9Q38582283-7003B6A2-2F09-4606-A25C-664EA7420083Q38842887-B85269D1-3DDC-4181-92FC-4723FA9A2032Q38897383-4794B67C-42EF-4F3E-8205-BC693BA234EAQ39592988-626B8F5F-67A2-48A8-B138-6120DBBB2C30Q41599473-40B945B8-C634-48FC-A4B8-F4321A5E9295Q44276603-38F7F052-9F39-4268-8122-09605D7722DBQ45937438-817429D4-9E41-4756-B235-D8C0DFA129E2Q45956057-CEE359D2-27A3-4727-8FE2-9FA30C2C6B7FQ47094970-A2791213-2017-48CC-9FD4-DECC90414122Q47566640-76B18B1D-B06E-4F0D-90A0-F7CE363DA638Q47612055-43662FDA-A040-4404-9030-1F8E32B4F7CEQ47783007-1048ED1D-5A1F-4570-9802-05F5BDA6997DQ48498648-FD2BC7C2-8448-4F19-B710-5D73A42B787BQ48572207-28A63684-E961-4110-8DB8-021E304F5E91Q50647633-44EFC40C-78EF-4E0A-8296-3FB6EF3A4B53Q51867792-68EE8C4B-BE69-42DB-AB65-0B9D4603C93FQ54355583-FBF7D8EC-0206-4847-86C3-FB9F4393087E
P2860
Administration of cyclophosphamide at different stages of follicular maturation in mice: effects on reproductive performance and fetal malformations.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
2001年论文
@zh
2001年论文
@zh-cn
name
Administration of cyclophospha ...... mance and fetal malformations.
@en
type
label
Administration of cyclophospha ...... mance and fetal malformations.
@en
prefLabel
Administration of cyclophospha ...... mance and fetal malformations.
@en
P2093
P2860
P356
P1433
P1476
Administration of cyclophospha ...... mance and fetal malformations.
@en
P2093
P2860
P304
P356
10.1093/HUMREP/16.4.632
P407
P577
2001-04-01T00:00:00Z